Inmune Bio INMB
INmune Bio Announces $13.0 Million Registered Direct Offering
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001213900-24-078783
- Document
- 8-K
- Exhibit 4.1
- Form of warrant
- Exhibit 10.1
- Form of securities purchase agreement
- Exhibit 10.2
- Form of placement agency agreement
- Exhibit 99.1
- Press release, dated September 13, 2024
- Signs a material agreement (1.01)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- Fitlife Brands FTLF public float $51M, Jun 30, 2025
- Immucell ICCC public float $51M, Jun 30, 2025
- Cue Biopharma CUE public float $52M, Jun 30, 2025
- Avalo Therapeutics AVTX public float $54M, Jun 30, 2025
- Precision Biosciences DTIL public float $47M, Jun 30, 2025
